The site includes data published by CMS on June 28. Drugmakers must release details of their payments to hospitals for promotional talks, research and consulting as well as other gifts.
Below are the top 20 companies and what they paid physicians in 2018:
1. Genentech — $478 million
2. Zimmer Biomet — $109 million
3. Stryker — $91.9 million
4. Boston Scientific — $82.2
5. Allergan — $73 million
6. Arthrex — $70.3 million
7. Medtronic — $66 million
8. Depuy Syntheses — $61.7 million
9. Pfizer — $48.9 million
10. AstraZeneca — $45 million
11. AbbVie — $42.9 million
12. Amgen — $41.4 million
13. Intuitive Surgical — $39.8 million
14. Medical Device Business Services — $39.1 million
15. Gilead Sciences — $38.6 million
16. Medtronic —$37.9 million
17. Merck — $37.4 million
18. Genzyme — $35.2 million
19. Abbott Laboratories — $33.8 million
20. Novartis — $32.1 million
More articles on supply chain:
Shortage of flu nasal spray expected this year
10 hospitals seeking supply chain talent
Sanford Health considering drone delivery for supplies
